申请人:KYOWA HAKKO KOGYO CO., LTD.
公开号:EP1649855A1
公开(公告)日:2006-04-26
The present invention provides a pharmaceutical composition which is useful in the treatment for bladder irritative symptoms accompanied by benign prostatic hyperplasia and the like, and comprises 3,3,3-trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c] [1]benzothiepin-9-yl)propanamide or a pharmaceutically acceptable salt thereof, and an α1-adrenoceptor antagonist.
本发明提供了一种药物组合物,可用于治疗伴随良性前列腺增生等症状的膀胱刺激症状,该药物组合物包含3,3,3-三氟-2-羟基-2-甲基-N-(5,5,10-三氧代-4,10-二氢噻吩并[3,2-c] [1]苯并噻吩-9-基)丙酰胺或其药学上可接受的盐,以及α1-肾上腺素受体拮抗剂。